← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2016-12-01

Drug application

FDA Application #

ANDA206505

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

DAPSONE

Active ingredients

DAPSONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

Manufacturer

ANI Pharmaceuticals, Inc.

First approval

2016-12-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown